Psychedelic Medicine After the Executive Order: Why the System Matters More Than the Molecule

A new chapter for psychedelic research

On April 18, 2026, the federal government signed an executive order designed to accelerate the study and accessibility of psychedelic therapies: psilocybin, ibogaine, MDMA, LSD, and ketamine for people living with serious mental illness.

The order calls on the FDA to expedite review pathways, allocates $50 million to support state-level research partnerships, and creates a mechanism for eligible patients to access investigational treatments before full approval.

For anyone who has struggled with depressionA prolonged low mood that interferes with life., anxietyA state of worry or tension that disrupts focus and sleep., PTSDA condition that can follow trauma, with symptoms like flashbacks, hyperarousal, and avoidance., or addictionA condition where the brain's reward system drives compulsive use of a substance or behavior, despite harm., especially those who have cycled through multiple medications without relief. This is real, meaningful progress. But if you’ve been on a long mental health journey, you’ve probably learned something along the way:

The next treatment isn’t automatically the answer.
How it’s delivered often matters more than what it is.

That’s the part of this story we want to focus on.

What the research actually shows

The science behind psychedelic medicine is promising. Substantial. Not speculative.

Clinical studies show that a single dose of psilocybin can lead to rapid improvements in treatment-resistant depressionDepression that persists despite adequate trials of antidepressant treatment., sometimes within days. In a 2025 study at the Palo Alto VA, roughly 60% of veterans with severe, long-standing depressionA prolonged low mood that interferes with life. responded to treatment, with a portion maintaining those gains a year later.

Similar signals are emerging across compounds:

• LSD in anxiety and depression
• MDMA in PTSD
• Ketamine in acute depressive states

For patients who have tried five, six, or seven other treatments without success, results like these can be life-changing.

But the same research reveals something that rarely makes headlines:

• Not everyone responds the same way
• Some improvements fade over time
• Long-term outcomes depend heavily on the support surrounding the treatment

The people who sustain meaningful change are typically those who receive structured preparation, thoughtful integrationThe process of making sense of and applying insights after a therapeutic experience such as ketamine therapy., and ongoing clinical support.

The medicine opens the door.
What happens around it determines whether that door stays open.

The real issue isn’t the medicine. It’s the system.

If you’ve spent time in the mental health system, this likely feels familiar.

Your therapist doesn’t always coordinate with your psychiatrist. Your psychiatrist rarely speaks with your primary care physician. Sleep, hormones, inflammation, and nutrition are often treated as side notes, if they’re addressed at all.

The model is still largely reactive: You describe symptoms → A prescription is written → You return in a few weeks.

Now we’re introducing powerful, fast-acting treatments like psychedelics into that same fragmented system. The question isn’t whether these compounds can help.

It’s whether the system delivering them is built to support lasting change.

At Fountain, we start from a different premise: mental health is biological before it is anything else. If your body is running on chronic sleep disruption, unresolved stressThe body's response to external demands. Chronic stress disrupts hormones, sleep, and immune function., hormonal imbalanceWhen hormones like cortisol, estrogen, or testosterone are too high or too low. Symptoms may include fatigue, mood swings, and weight shifts., or systemic inflammation, even a breakthrough intervention can struggle to take hold—not because you aren’t trying, but because your system isn’t supported in a way that allows change to stabilize.

Fountain’s perspective: powerful tools, incomplete on their own

Speaking to Military.com about the executive order, Fountain Health co-founder Nikita Tsimmer described it as an important step forward, particularly for veterans who haven’t responded to conventional care. But he also pushed back on a common misconception: that a new compound, by itself, will solve a fundamentally incomplete care model. His point is simple, and it’s the same one we return to with every patient:

A psychedelic is a tool.
The system around it determines the outcome.

Treatments like psilocybin, ibogaine, MDMA, and ketamine can create a window of change. But what happens within that window, and how the body and nervous system are supported afterward, is what transforms a temporary shift into something durable.

What we’re ultimately trying to help patients reach is a state where their system can actually hold progress, where improvements don’t just appear, but persist.

Why protocol matters

Most conversations about psychedelics focus on the session itself. In reality, the session is only a fraction of the outcome. A well-run session might account for 10% of long-term results. The other 90% is everything around it:

Preparation.
Physiological support.
IntegrationThe process of making sense of and applying insights after a therapeutic experience such as ketamine therapy..
Follow-through.

What most people don’t see is that this is where outcomes are actually determined. At Fountain Health, what happens before and after the actual treatment is key. (Read more about The Fountain Health 4-Phase Ketamine Therapy Framework™)

Our approach starts from a simple idea: the body is one system, not a collection of isolated parts. That means when someone comes to us for advanced mental health treatment, whether it’s ketamine today or a newly approved psychedelic in the future, we build a real-time clinical understanding of how their system is functioning, and we continue refining that understanding as treatment unfolds.

A Fountain Health protocol typically includes:

• Comprehensive evaluation
  Not just symptoms, but sleep, metabolic health, hormones, inflammation, nutrient status, gut health, and nervous system regulation.
• Targeted biological support
  Before, during, and after treatment. If something is limiting your ability to respond, e.g.: sleep, inflammation, endocrine function, we address it directly.
• Continuous clinical adjustment
  This is where clinical intelligence matters. It’s not just about measuring your system, it’s about adapting care in response to how you’re actually doing, over time.
• Long-term tracking
  We look at 3, 6, and 12 months, not just short-term response, because real recovery isn’t an event, it’s a trajectory.

The goal isn’t a temporary lift.
It's a system that can sustain change.

What this means for patients

As the effects of the executive order unfold, more treatment options will likely become available, and faster than expected. That’s good news. But as access expands, a few things matter just as much:

The clinic matters as much as the compound.
Look for teams that understand your full medical picture and support you between sessions—not just during them.

Your biology is part of your mental health.
Sleep, inflammation, hormones, nutrition, and nervous system regulation all shape how you feel, and how well any treatment works.

You are not the problem.
If past treatments haven’t worked, it’s often because the system treating you was incomplete—not because you failed.

The path forward

This executive order is a beginning. It will accelerate research, expand access, and bring hope to people who have been waiting for something new. But the future of mental health care isn’t just better molecules.

It’s better systems.

Systems that:

• Treat the whole person
• Adapt over time, not just at intake
• Support the biology that makes change possible
• Stay engaged over the long arc of recovery

That’s what we’re building at Fountain Health. And it’s why, as new breakthroughs emerge, we’ll keep coming back to the same idea:

The medicine matters.
The system around it matters more.

###

Fountain Health is a precision, whole-body mental health practice in New York City, offering IV ketamine therapy, integrative psychiatry, hormonal and metabolic care, and longevity medicine—all designed around the one system that matters most: YOU. Learn more about our approach →